dc.contributor.author | Brocklesby, KL | |
dc.contributor.author | Waby, JS | |
dc.contributor.author | Cawthorne, C | |
dc.contributor.author | Smith, G | |
dc.date.accessioned | 2017-03-24T14:22:54Z | |
dc.date.issued | 2017-04-12 | |
dc.identifier.citation | Tetrahedron letters, 2017, 58 (15), pp. 1467 - 1469 | |
dc.identifier.issn | 0040-4039 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/497 | |
dc.identifier.doi | 10.1016/j.tetlet.2017.02.082 | |
dc.description.abstract | Vandetanib is an orally available tyrosine kinase inhibitor used in the treatment of cancer. The current synthesis proceeds via an unstable 4-chloroquinazoline, using harsh reagents, in addition to requiring sequential protection and deprotection steps. In the present work, use of the Dimroth rearrangement in the key quinazoline forming step enabled the synthesis of Vandetanib in nine steps (compared to the previously reported 12-14). | |
dc.format | Print | |
dc.format.extent | 1467 - 1469 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.title | An alternative synthesis of Vandetanib (Caprelsa™) via a microwave accelerated Dimroth rearrangement. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2017-02-27 | |
rioxxterms.versionofrecord | 10.1016/j.tetlet.2017.02.082 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2017-04 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Tetrahedron letters | |
pubs.issue | 15 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/PET Radiochemistry | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/PET Radiochemistry | |
pubs.publication-status | Published | |
pubs.volume | 58 | |
pubs.embargo.terms | Not known | |
icr.researchteam | PET Radiochemistry | |
dc.contributor.icrauthor | Smith, Graham | |